About us Chiesi is an international research-focused biopharmaceutical group with 90 years’ experience, operating in more than 30 countries, with its Headquarter in Parma, Italy. More than 8,000 employees across the group are united by a
About us Chiesi is an international research-focused biopharmaceutical group with 90 years’ experience, operating in more than 30 countries, with its Headquarter in Parma, Italy. More than 8,000 employees across the group are united by a
About us Chiesi is an international research-focused biopharmaceutical group with 90 years’ experience, operating in more than 30 countries, with its Headquarter in Parma, Italy. More than 8,000 employees across the group are united by a
Chiesi seeks a Regulatory Affairs (RA) Senior Manager with strong CMC pre/post-approval experience to support the Global Rare Diseases portfolio. You will lead CMC documentation, author sections, and advise on regulatory strategies across global submissions. The role emphasizes
Chiesi Farmaceutici S.p.A. in Parma, IT, seeks an experienced senior CMC leader for protein biologics drug substance development within GRD CMC. You will lead upstream/downstream development, analytical control strategies, comparability, and lifecycle management for recombinant protein therapeutics. The
Chiesi Farmaceutici S.p.A. is seeking a GRD Technical Leader to manage budget, strategy, and execution for CMC development and IMP supply. The role directs ETT workstreams, collaborates with CT and product teams, and leads external partners to
Chiesi Farmaceutici S.p.A. in Parma, IT, seeks an experienced Senior Technical Leader for Analytical Method Development and Validation in GRD CMC. You will lead analytical strategy, development plans, and lifecycle activities for biologics, partnering with CDMOs, CROs,
Chiesi in Parma seeks a senior leader to drive industrialization and lifecycle management of upstream biopharmaceutical processes. You will lead insourcing, tech transfer, scale‑up, and validation across development to commercial production. The role interfaces with R&D,